uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
No other interest can take precedence: a patient's perspective on oncology drug development
Uppsala University, Disciplinary Domain of Science and Technology, Biology, Department of Organismal Biology, Evolution and Developmental Biology. Melanoma Patient Network Europe, Uppsala, Sweden.
2019 (English)In: Nature Reviews Clinical Oncology, ISSN 1759-4774, E-ISSN 1759-4782, Vol. 16, no 8, p. 461-462Article in journal, Letter (Other academic) Published
Place, publisher, year, edition, pages
Nature Publishing Group, 2019. Vol. 16, no 8, p. 461-462
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-391428DOI: 10.1038/s41571-019-0230-4ISI: 000476653800002PubMedID: 31110270OAI: oai:DiVA.org:uu-391428DiVA, id: diva2:1357363
Available from: 2019-10-03 Created: 2019-10-03 Last updated: 2019-10-03Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Ryll, Bettina

Search in DiVA

By author/editor
Ryll, Bettina
By organisation
Evolution and Developmental Biology
In the same journal
Nature Reviews Clinical Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 5 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf